SCHEMBL6665787

SCHEMBL6665787

CCOCn1cnc2c1c(=O)n(Cc1ccc(C)cc1F)c(=O)n2-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.38
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 2/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
TP53 P04637 1/20 0.37
HPGD P15428 3/20 0.37
TSHR P16473 3/20 0.37
HSD17B10 Q99714 2/20 0.37
RXFP1 Q9HBX9 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
THRB P10828 1/20 0.35
POLB P06746 1/20 0.35
HIF1A Q16665 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6665236 0.83 KMT2A (0.51) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1
SCHEMBL6659535 0.79 LMNA (0.47) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1
SCHEMBL6665174 0.79 KMT2A (0.46) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1
SCHEMBL6660040 0.79 KMT2A (0.44) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1
SCHEMBL6666190 0.79 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1
SCHEMBL6663376 0.78 KMT2A (0.49) ALDH1A1LMNAKMT2AMEN1TP53
SCHEMBL6663336 0.78 TAS2R8 (0.41) SMN1; SMN2ALDH1A1NPSR1LMNAKMT2A
SCHEMBL6661011 0.77 POLB (0.50) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1
SCHEMBL6661746 0.77 KMT2A (0.44) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1
SCHEMBL6662150 0.76 KMT2A (0.45) SMN1; SMN2ALDH1A1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1257552-B1 XANTHINE DERIVATIVES, INTERMEDIATES AND USE FOR TREATING OSTEOPOROSIS AVENTIS PHARMA SA (FR) 2004-08-18 EP disclosed